An expert panel recently called for universal lipid screening in children, a controversial recommendation that will require practice changes by pediatricians and the clinical labs that support them.
Driven by expanding test volumes and unrelenting pressure to cut costs and reduce errors, labs have become experts at efficiency. But what happens after you’ve trimmed all the fat? With few options left, automation solutions that previously seemed out of reach for the majority of labs have now become not just a possibility, but a necessity.
Identifying and detecting autoantibodies in the serum and cerebral spinal fluid of patients who display a variety of neurological signs and symptoms has become a significant diagnostic aid to clinicians.
Proposed new blood lead level thresholds could dramatically boost the pediatric population considered to have lead poisoning and require changes in how labs report results.
Direct Patient Access to Test ResultsNext Generation Sequencing Coming to Clinical Labs